Back to Journals » Journal of Experimental Pharmacology » Volume 14

Original Research

Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis

       
Total article views   HTML views PDF downloads Totals
6,515 Dovepress* 6,244+ 367 6,611
PubMed Central* 271 66 337
Totals 6,515 433 6,948
*Since 9 February 2022
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar